Repetitive TMS of the Default Mode Network in AD (TMS-AD)
Repetitive TMS of the Precuneus: a Randomized Double-blinded Placebo-controlled Trial in Alzheimer's Disease Patients.
Sponsor: I.R.C.C.S. Fondazione Santa Lucia
Listed as NCT03778151, this NA trial focuses on Alzheimer Disease and remains completed. Sponsored by I.R.C.C.S. Fondazione Santa Lucia, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
May 2020 — Aug 2020 [monthly]
Recruiting NA
-
Jan 2019 — May 2020 [monthly]
Recruiting NA
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- I.R.C.C.S. Fondazione Santa Lucia
For direct contact, visit the study record on ClinicalTrials.gov .